| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H22F3N7OS |
| Molecular Weight | 465.495 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1N=CC(NC(=O)C2=C(N)SC(=N2)C3=C(F)C=CC=C3F)=C1N4CC[C@@H](N)[C@H](F)CC4
InChI
InChIKey=NHXVGMQFCYBLTL-ZWNOBZJWSA-N
InChI=1S/C20H22F3N7OS/c1-29-20(30-7-5-10(21)13(24)6-8-30)14(9-26-29)27-18(31)16-17(25)32-19(28-16)15-11(22)3-2-4-12(15)23/h2-4,9-10,13H,5-8,24-25H2,1H3,(H,27,31)/t10-,13-/m1/s1
| Molecular Formula | C20H22F3N7OS |
| Molecular Weight | 465.495 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.03 nM [IC50] | |||
| 0.1 nM [IC50] | |||
| 0.02 nM [IC50] |
